*

Hitt og þetta 25. júlí 2007

Directors' interests in shares

25 July 2007, Godalming, UK. Sinclair Pharma plc ("Sinclair") (SPH.L) announces that the following Directors have today been granted Performance Share Awards ("Awards") under the Sinclair Pharma plc 2003 Executive Incentive Plan: Director Awards Dr Michael Flynn 242,009 Jerry Randall 194,521 The Awards are granted over ordinary 1p shares in Sinclair and are based on a share price of 109.5p per share. The awards have a three year vesting period and vesting is subject to certain share price performance criteria over the period. No amount was payable by the Directors on the grant of these Awards. An exercise price of 1p is payable in respect of each Award exercised. Dr Flynn and Mr Randall notified Sinclair of their respective interests in these shares on 25 July 2007. Ends For further information please contact: Sinclair Pharma plc Tel: +44 (0)1483 410 600 Dr Michael Flynn, CEO Jerry Randall, CFO Zoe McDougall, Director of investorrelations@sinclairpharma.com Communications Capital MS&L Mary Clark Tel +44 (0)20 7307 5340 Halina Kukula ---END OF MESSAGE---